Buy Crypto Markets Spot FuturesGOLD Earn Event Center

BioStem Technologies announces presentation at 46th Annual TD Cowen Healthcare Conference to showcase perinatal tissue-derived regenerative therapies and proprietaryBioStem Technologies announces presentation at 46th Annual TD Cowen Healthcare Conference to showcase perinatal tissue-derived regenerative therapies and proprietary

BioStem Technologies to Present at Major Healthcare Investment Conference

Author: Citybuzz

Source: Citybuzz

2026/02/20 20:01

2 min read

MAJOR$0.0613+0.13%

For feedback or concerns regarding this content, please contact us at [email protected]

BioStem Technologies, Inc. announced that company management will present at the 46th Annual TD Cowen Healthcare Conference in Boston, Massachusetts. The presentation is scheduled for Monday, March 2, 2026, at 3:50 pm Eastern Time. This appearance at a prominent investment conference provides BioStem with a platform to communicate its business strategy and technological developments to the financial community.

The company specializes in developing, manufacturing, and commercializing perinatal tissue-derived products for advanced wound care. Its focus on regenerative therapies utilizes tissue allografts processed through its proprietary BioRetain® method. This technology aims to maintain growth factors and preserve tissue structure, which are critical for effective healing applications. The company’s operations comply with current Good Tissue Practices and current Good Manufacturing Processes, and its systems are accredited by the American Association of Tissue Banks.

BioStem’s product portfolio includes several brands such as VENDAJE®, VENDAJE AC®, American Amnion, American Amnion AC, and the Neox® and Clarix® product lines. These products are designed to address complex wound care needs through biological solutions. Interested parties can access a live webcast of the conference presentation, along with an archived version, through the investors section of the company’s website at https://ir.biostemtechnologies.com.

The presentation at the TD Cowen conference represents a significant opportunity for BioStem to engage with investors and analysts during a period of growth in the regenerative medicine sector. The company’s emphasis on perinatal tissue products positions it within a specialized niche of the medical technology market. For additional information about the company and its products, visit https://biostemtechnologies.com. The latest company news and updates are also available through its newsroom at https://tinyurl.com/bsemnewsroom.

This news story relied on content distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is BioStem Technologies to Present at Major Healthcare Investment Conference.

The post BioStem Technologies to Present at Major Healthcare Investment Conference appeared first on citybuzz.

Market Opportunity

Major Price(MAJOR)

$0.0613

$0.0613$0.0613

+0.65%

USD

Major (MAJOR) Live Price Chart

SPACEX(PRE) Launchpad Is Live

Start with $100 to share 6,000 SPACEX(PRE)

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

Tags:

#SEC